KFA Private Wealth Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
KFA Private Wealth Group's AZN Position: Q3 2026 in Review
KFA Private Wealth Group sold out of AstraZeneca (AZN) in Q3 2026, closing a stake of 1,212 shares — an estimated $230K sold.
KFA Private Wealth Group first reported a position in AZN in Q1 2025 and held it in 4 quarters. The position peaked at $306K in Q1 2026. 782 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- KFA Private Wealth Group reported no remaining AstraZeneca position as of Q3 2026 after selling out during the quarter.
- KFA Private Wealth Group sold 1,212 AstraZeneca shares in Q3 2026, an estimated $230K.
- KFA Private Wealth Group first reported a position in AstraZeneca in Q1 2025 and held it in 4 quarters.
- KFA Private Wealth Group's AstraZeneca position peaked at $306K in Q1 2026.
- 782 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on KFA Private Wealth Group's 13F filing for Q3 2026, filed 7 Oct 2026.